Cullinan Oncology Inc. (CGEM) PT Lowered to $38 at Morgan Stanley
Morgan Stanley analyst Jeffrey Hung lowered the price target on Cullinan Oncology Inc. (NASDAQ: CGEM) to $38.00 (from $40.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)